Skip to content

Nonprofit

The Transplantation Society

The Transplantation Society receives grants from 1 organization whose IRS filings report $10,000 to it, the largest being President and Fellows of Harvard College ($10,000). 0 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2024
$4.9M
Funders on record
1
Grants received
$10k
Net assets
$12M
0/1 repeat funderspeak grant-dependency 0%
01What it does

What The Transplantation Society does

Mission

The Transplantation Society provides the focus for global leadership in transplantation for the development of the science and clinical practice, scientific communication, continuing education and guidance on the ethical practice.

As stated on its FY2024 Form 990.

Programs

  1. Program and magazine publications including website development and webinars available to members only. These publications relate specifically to the field of organ transplantation.

    $679,865 spent$1,057,445 earned by the program
    45% of program spending
  2. See schedule o an international forum for the world-wide advancement of organ transplantation including a focus on - development of the science and clinical practice - scientific communication - continuing education -guidance on the ethical practice of transplantation. The organization achieves this focus by making grants to section and regional societies for the purpose of travel, research fellowship, and recognizing individuals who have made outstanding contributions in transplantation. The primary awards and grants are: 1) the medawar prize, named after society co-founder sir peter medawar, is recognized as the world's highest dedicated award for the most outstanding contributions in the field of transplantation. The medawar prize has been awarded to two or more recipients at each of the organization's biennial congresses since 1990. The award is made possible by a generous grant from novartis pharma ag who agreed that a prestigious prize be established and maintained to recognize the outstanding investigators whose contributions have had such a profound influence on the field of organ transplantation. 2) tts thomas starzl innovation award. Named after tom starzl who was best…

    $336,550 spentof which $336,550 as grants
    22% of program spending
  3. See schedule o events held in a variety of global venues where members of the community are brought together to discuss advancements in organ transplantation. Organ transplantation is a successful therapy for end stage organ failure of the kidney, liver, heart, lung, pancreas and intestine. Transplantation of cells and tissues also transformed the therapeutic options for patients with malignant haematological disease, eye disease and orthopaedic disease, and has the potential to alter significantly the therapeutic options for patients with diabetes and a range of disorders. The access of patients to transplantation therapy varies widely across the globe, partly determined by the underlying level of economic development in different states and partly determined by other factors such as the availability of organ, cell and tissue donors, or the specialized provision of health services. The organization has determined that it will seek to address global inequities in transplantation therapy, in order to facilitate appropriate access to transplantation for all patients who would benefit.

    $509,721 spent$399,083 earned by the program
    33% of program spending

The 3 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $1,526,136.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($2.3M) Expenses 100 ($2.2M) Net assets 100 ($9.9M)2018 Revenue 232 ($5.3M) Expenses 199 ($4.4M) Net assets 101 ($10.0M)2019 Revenue 95 ($2.2M) Expenses 99 ($2.2M) Net assets 110 ($11M)2020 Revenue 99 ($2.3M) Expenses 87 ($1.9M) Net assets 120 ($12M)2021 Revenue 88 ($2.0M) Expenses 82 ($1.8M) Net assets 126 ($13M)2022 Revenue 184 ($4.2M) Expenses 181 ($4.0M) Net assets 111 ($11M)2023 Revenue 105 ($2.4M) Expenses 117 ($2.6M) Net assets 119 ($12M)2024 Revenue 213 ($4.9M) Expenses 203 ($4.5M) Net assets 126 ($12M)
'17'18'19'20'21'22'23'24
Revenue (213)Expenses (203)Net assets (126)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $15M to $13M (−17%).

$12M
$11M
$12M
$13M
$15M
$13M
$13M
$14M
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

14% of The Transplantation Society’s revenue is contributions — about as donation-reliant as the typical peer (51% for the typical peer).

This organization
Typical peer · 8,611 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 8 reported years ran a deficit.

$85k
’17
$930k
’18
$8k
’19
$352k
’20
$204k
’21
$229k
’22
−$176k
’23
$384k
’24
2.1
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

2017201820192020202120222024
Listed20252029222832
Joined·+5+1+10+1+7·
No longer listed·06181·
03Who funds it

Who funds it, year by year

Grant support over time, funder by funder — shade shows the grant size each year.

Funder
'23
total
funders
1

1 of 1 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 100% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of The Transplantation Society’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

The Transplantation Society runs a healthier operating margin than half of the 8,121 health nonprofits its size.

Operating margin8% · above the median
Months of reserve2.1mo · below the median
Revenue growth (annualized)11% · above the median

this organization peer median middle 50% of peers· 8,121 health nonprofits $1M–$10M, FY2024

Organizations like The Transplantation Society

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

74% of spending goes to programs.

Program 74%Management 26%Fundraising 0%

Governance

21
board members
100%
independent
✓Conflict-of-interest policy–Whistleblower policy–Document retention✓Board reviewed the 990✓Audited financials

Public support

44%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Screen this organization

A dated, signed PDF of the compliance screen for The Transplantation Society: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds The Transplantation Society?
The Transplantation Society receives grants from 1 organization whose IRS filings report $10,000 to it, the largest being President and Fellows of Harvard College ($10,000). 0 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does The Transplantation Society have?
IRS filings report 1 organization giving $10,000 in grants to The Transplantation Society.
Who is the largest funder of The Transplantation Society?
President and Fellows of Harvard College is the largest funder on record, with $10,000 in grants. The full list of funders is on this page.
How can an organization like The Transplantation Society find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing